Nanhua Bio Medicine Co Ltd Market Cap ($384.41 Million)
Market Cap & Net Worth: Nanhua Bio Medicine Co Ltd (000504)
Nanhua Bio Medicine Co Ltd market cap. Nanhua Bio Medicine Co Ltd (SHE:000504) has a market capitalization of $384.41 Million (CN¥2.63 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #13314 globally and #3912 in its home market, demonstrating a -4.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanhua Bio Medicine Co Ltd's stock price CN¥7.96 by its total outstanding shares 330023098 (330.02 Million). Also see Nanhua Bio Medicine Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Nanhua Bio Medicine Co Ltd Market Cap History (2015–2026)
Nanhua Bio Medicine Co Ltd market cap history from 2015 to 2026. Data shows change from $1.45 Billion to $384.41 Million (-6.82% CAGR). Check latest Nanhua Bio Medicine Co Ltd stock price today for real-time trading data and today's change.
Nanhua Bio Medicine Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanhua Bio Medicine Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000504 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.04x
Nanhua Bio Medicine Co Ltd's market cap is 1.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.99x
Nanhua Bio Medicine Co Ltd's market cap is 14.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $800.21 Million | $67.25 Million | $21.76 Million | 11.90x | 36.78x |
| 2017 | $1.13 Billion | $67.39 Million | -$37.12 Million | 16.84x | N/A |
| 2018 | $602.21 Million | $95.38 Million | -$35.19 Million | 6.31x | N/A |
| 2019 | $390.21 Million | $134.16 Million | $18.81 Million | 2.91x | 20.75x |
| 2020 | $591.10 Million | $175.56 Million | $8.15 Million | 3.37x | 72.49x |
| 2021 | $898.25 Million | $156.62 Million | -$19.13 Million | 5.74x | N/A |
| 2022 | $562.13 Million | $200.35 Million | -$12.46 Million | 2.81x | N/A |
| 2023 | $560.20 Million | $136.79 Million | -$28.17 Million | 4.10x | N/A |
| 2024 | $403.24 Million | $134.45 Million | -$19.85 Million | 3.00x | N/A |
| 2025 | $432.22 Million | $415.94 Million | $28.83 Million | 1.04x | 14.99x |
Competitor Companies of 000504 by Market Capitalization
Companies near Nanhua Bio Medicine Co Ltd in the global market cap rankings as of November 6, 2026. Also see Nanhua Bio Medicine Co Ltd total assets for a full breakdown of the balance sheet.
Key companies related to Nanhua Bio Medicine Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Nanhua Bio Medicine Co Ltd (2015–2026)
Market capitalization of Nanhua Bio Medicine Co Ltd from 2015 to today. Between 2015 and today, Nanhua Bio Medicine Co Ltd's market cap moved from $1.45 Billion to $ 384.41 Million, with a yearly change of -6.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥384.41 Million | -11.06% |
| 2025 | CN¥432.22 Million | +7.19% |
| 2024 | CN¥403.24 Million | -28.02% |
| 2023 | CN¥560.20 Million | -0.34% |
| 2022 | CN¥562.13 Million | -37.42% |
| 2021 | CN¥898.25 Million | +51.96% |
| 2020 | CN¥591.10 Million | +51.49% |
| 2019 | CN¥390.21 Million | -35.20% |
| 2018 | CN¥602.21 Million | -46.94% |
| 2017 | CN¥1.13 Billion | +41.82% |
| 2016 | CN¥800.21 Million | -44.73% |
| 2015 | CN¥1.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Nanhua Bio Medicine Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $384.41 Million USD |
| MoneyControl | $384.41 Million USD |
| MarketWatch | $384.41 Million USD |
| marketcap.company | $384.41 Million USD |
| Reuters | $384.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment provides stem cell and immune cell testing, storage, and technical services; as well as sales of biopharmaceutical products, such as beauty products, health supplements, and air purifiers. The Energy Saving and… Read more